AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results
Go back to AbbVie Reports Full-Year and Fourth-Quarter 2021 Financial Results| AbbVie (NYSE: ABBV) | Delayed: 216.49 -4.74 (2.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.23 | 52 Week High | $68.12 | |||
| Open | $221.37 | 52 Week Low | $50.71 | |||
| Day High | $222.35 | P/E | 46.96 | |||
| Day Low | $215.37 | EPS | $4.61 | |||
| Volume | 9,646,087 | |||||
| (NASDAQ: IMAB) | Delayed: 4.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $ | |||
| Open | $4.63 | 52 Week Low | $ | |||
| Day High | $4.63 | P/E | N/A | |||
| Day Low | $4.63 | EPS | $ | |||
| Volume | 42,292 | |||||
